US Bancorp DE Sells 1,756 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

US Bancorp DE lessened its holdings in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 57.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,290 shares of the construction company’s stock after selling 1,756 shares during the quarter. US Bancorp DE’s holdings in Aspen Aerogels were worth $36,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Dakota Wealth Management acquired a new position in Aspen Aerogels during the third quarter worth $986,000. Comerica Bank bought a new stake in shares of Aspen Aerogels in the 1st quarter worth about $1,992,000. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Aspen Aerogels by 66.7% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock worth $1,922,000 after purchasing an additional 32,243 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after purchasing an additional 175,906 shares during the last quarter. Finally, Hsbc Holdings PLC acquired a new position in Aspen Aerogels in the second quarter valued at about $732,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

ASPN has been the subject of a number of research reports. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Wednesday, November 13th. Roth Mkm decreased their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. Benchmark reiterated a “buy” rating and issued a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. Piper Sandler cut their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Finally, TD Cowen increased their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and a consensus price target of $28.70.

Get Our Latest Analysis on Aspen Aerogels

Insider Activity at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This represents a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

Aspen Aerogels Stock Up 1.5 %

Aspen Aerogels stock opened at $14.50 on Tuesday. Aspen Aerogels, Inc. has a 1-year low of $10.19 and a 1-year high of $33.15. The company has a market cap of $1.19 billion, a P/E ratio of 1,428.00 and a beta of 2.21. The company has a current ratio of 2.93, a quick ratio of 2.82 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $22.04 and a 200 day simple moving average of $24.72.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.